Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Creo Pharma is a UK-based pharmaceutical company that specializes in the sourcing, licensing, and marketing of generic medicines. Founded in 2007 and headquartered in Canterbury, the company provides a diverse portfolio of prescription products to the UK retail pharmacy and hospital sectors. In 2013, Creo Pharma was acquired by Amneal Pharmaceuticals, a global leader in generics, which integrated the company into its international supply chain and significantly expanded its product offerings. The company focuses on delivering cost-effective healthcare solutions and maintaining a reliable supply of essential medicines across various therapeutic areas. As a subsidiary of Amneal, it leverages global manufacturing capabilities to serve the UK market with high-quality generic alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Creo Pharmaceuticals.